EDIT vs WMT · rev $32.3M vs P/E 42, rev $713.16B
Editas Medicine Inc (EDIT) versus Walmart Inc (WMT) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Walmart Inc (WMT) is a discount stores company listed on US. It is led by Doug McMillon.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported WMT revenue for 2026-01-31 was $713.16B. Net income was $21.89B. Revenue was up 4.7% from 2025-01-31 to 2026-01-31. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
EDIT currently screens at market cap $375.2M. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
Not investment advice. Open the EDIT and WMT stock pages for the full models.
Not investment advice.